ai
Firefly Neuroscience
AIFF
NASDAQ $1.04
Does Firefly Neuroscience have high-quality management?
Leadership changed in 2025, with Greg Lipschitz elevated to CEO; the board includes executives with medtech and AI backgrounds.
Execution has delivered device deployments and revenue growth from a low base, yet persistent going‑concern language, reliance on equity capital and warrant structures, and limited operating scale temper our view of capital discipline.
Geographic exposure to Israel‑based R&D and talent also adds operational risk during regional hostilities, as disclosed.
Read the full report on Firefly Neuroscience and explore the other sections
Overview of Firefly Neuroscience
Does Firefly Neuroscience have a strong competitive moat?
Does Firefly Neuroscience have pricing power in its industry?
How predictable is Firefly Neuroscience's business?
Is Firefly Neuroscience financially strong?
How effective is Firefly Neuroscience's capital allocation strategy?
Does Firefly Neuroscience have high-quality management?
What is the fair value of Firefly Neuroscience stock?